Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

MiR-378a-3p Promotes Macrophage Polarization from M1 to M2 for Cardiac Repair after Infarction Via Trem1.

Created on 12 Jul 2026

Authors

Ming Shen, Tongxuan Li, Xuan Jiang, Zichang Wang, Ningbo Liu, Peihong Wu, Gang Wang, Mingqi Zheng

Published in

Journal of cardiovascular translational research. Volume 19. Issue 1. Jul 11, 2026. Epub Jul 11, 2026.

Abstract

Acute myocardial infarction (AMI) triggers a robust inflammatory response in which macrophage polarization critically influences cardiac repair, yet the regulatory role of microRNAs remains largely undefined. Through integrated analysis of GEO datasets and experimental validation in hypoxic Raw264.7 cells and a mouse AMI model, we identified that miR-378a-3p is significantly downregulated following ischemic injury. Administration of miR-378a-3p mimics in vitro or miR-378a-3p agomir in vivo suppressed M1 macrophage polarization, attenuated inflammatory cytokine production, and markedly improved cardiac function and remodeling after AMI. Mechanistically, miR-378a-3p directly bound the 3'UTR of Trem1 mRNA, and Trem1 overexpression reversed the anti-inflammatory effects of miR-378a-3p, confirming Trem1 as a functional target. This study unveils the miR-378a-3p/Trem1 axis as a critical regulator of post-infarction inflammation and identifies miR-378a-3p as a promising therapeutic candidate for mitigating acute cardiac injury and improving outcomes in AMI patients.

PMID:
42436353
Bibliographic data and abstract were imported from PubMed on 12 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement